1 Crispr Therapeutics Ag Receivables Turnover Ratio (CRSP), from the first quarter 2026 to the first quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Crispr Therapeutics Ag  (NASDAQ: CRSP)
 

Crispr Therapeutics Ag Accounts Receivables Turnover Ratio from the first quarter 2026 to the first quarter 2025

Quarterly Results, Trends, Rankings, Statistics


According to Crispr Therapeutics Ag Balance Sheet, in the first quarter 2026, company has not reported any Accounts receivable.
See Crispr Therapeutics Ag Balance Sheet

If we take a look into Healthcare sector 556 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2026 from 3420 to 3753.

What is Receivable Turnover Ratio?
What is Crispr Therapeutics Ag Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CRSP Receivables Turnover Ratio (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 68.55 % -97.58 % 47.67 % 72.53 % 71.63 %
Receivable Turnover Ratio (TTM) - - 6.13 6.09 6.03
CRSP's Total Ranking # 3753 # 3420 # 3521 # 3420 # 1843
Accounts Receivable average collection period days - - 60 60 61
Seq. Receivable Change - - - - -
Seq. Revenue Change 68.75 % -2.81 % -0.34 % 3.12 % -97.58 %


Receivable Turnover Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 70
Healthcare Sector # 557
Overall Market # 3753

Receivable Turnover Ratio Statistics
High Average Low
0.44 0.13 0
(Jun 30 2021)   (Dec 31 2022)





CRSP Company Profile • Back to CRSP Efficiency Comparisons • Compare CRSP Receivables Turnover Ratio to its Competitors

Financial Statements
Crispr Therapeutics Ag's Accounts Receivable $ 0 Millions Visit CRSP's Balance sheet
Crispr Therapeutics Ag's Sales TTM $ 4 Millions Visit CRSP's Income Statement
Sources of CRSP's Revenues Visit CRSP's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CRSP's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CRSP's Growth Rates CRSP's Roa CRSP's Inventory Turnover Ratio CRSP's Dividend Comparisons
CRSP's Profitability Ratios CRSP's Roi CRSP's Asset Turnover Ratio CRSP's Dividend Growth
CRSP's Valuation Ratios CRSP's Roe CRSP's Financial Strength Ratios CRSP's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Mar 31 2026 Receivable at quarter ending Mar 31 2026

Date modified: 2026-08-29T17:37:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.